Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders. Disc Medicine is building a unique portfolio of innovative, first-in-class therapeutic candidates that affect fundamental pathways of red blood cell biology.

Biotechnology

Disc Medicine

Disc Medicine's headquarters in Cambridge, MA, United States

John Quisel

Steve Caffé

Tamara McGrillen

Rahul Rajan Kaushik

Gene Lichtman

Pamela Stephenson

Jean Franchi

Rahul Khara

Will Savage

Jonathan Yu

Jay T. Backstrom

Mark Chin

Mona Ashiya

Srdan Verstovsek

Tomas Ganz

Mark Fleming

Brian MacDonald

Elizabeta Nemeth

Stefano Rivella

Uma Sinha

Georges Gemayel

Liam Ratcliffe

Donald Nicholson

Kevin Bitterman

William White

The Research and Development team at Disc Medicine focuses on discovering and developing innovative therapies for hematologic disorders. This multidisciplinary team conducts comprehensive biological research, manages clinical development operations, oversees regulatory compliance, and ensures the efficacy and safety of novel therapeutic candidates. Their collaborative efforts aim to advance the understanding of red blood cell biology and drive the progression of first-in-class treatments from concept to clinical application.

Research and Development

The Directors Team at Disc Medicine is responsible for guiding the strategic direction and critical decision-making processes of the company. Comprising leaders from various disciplines, this team collaborates to ensure alignment on corporate strategy, business development, and the advancement of innovative therapies for hematologic disorders.

Directors Team

The Leadership Team at Disc Medicine spearheads the strategic direction and operational execution of the company’s mission to advance innovative therapies for hematologic disorders. Comprised of experts in clinical pharmacology, chemistry, and business, this team collaborates to drive research initiatives, oversee drug development processes, and foster partnerships that enhance the company's portfolio of therapeutic candidates. Their collective expertise ensures that Disc Medicine remains at the forefront of biopharmaceutical innovation, dedicated to improving patient outcomes.

Leadership Team

The Scientific Advisory Team at Disc Medicine provides expert guidance on the development of innovative, first-in-class therapeutic candidates aimed at treating hematologic disorders. Comprised of multiple Scientific Advisors, the team collaborates to shape research strategies, optimize clinical development plans, and ensure scientific rigor in the pursuit of transforming patient care.

Scientific Advisory Team

The Finance Team at Disc Medicine is responsible for managing the company's financial health, including budgeting, forecasting, and financial reporting. They ensure optimal allocation of resources to support the development of innovative therapeutic candidates for hematologic disorders. The team also provides strategic financial insights to guide executive decision-making and maintain compliance with regulatory requirements.

Finance Team

The Legal Team at Disc Medicine ensures compliance with healthcare regulations, manages intellectual property to protect innovative therapies, oversees legal operations, and handles contracts to support business activities and strategic initiatives. This team works to safeguard the company's interests and facilitates the smooth operational execution of its hematologic disorder treatments.

Legal Team

Disc Medicine

Org chart

Board & advisors

Teams

Research and Development

Directors Team

Leadership Team

Scientific Advisory Team

Finance Team

Legal Team

Offices

Disc Medicine

Org chart

Board & advisors

Teams

Research and Development

Directors Team

Leadership Team

Scientific Advisory Team

Finance Team

Legal Team

Offices

Related companies